chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At PNEUMOVAX site: 10cm x 10cm area of redness warmth and induration fever 101.7 max, low 100.3. Tx: rest, IB QID, Benadryl 50mg q6 prm.
Second dose was to be Moderna but client received pfizer at a covid event. Notified one day later per family member.
ED to Hosp-Admission Discharged  4/1/2021 - 4/5/2021 (4 days)   INPATIENT DISCHARGE SUMMARY   Admission diagnosis:     Primary Admission Diagnosis    Hospital Problems          POA   * (Principal) Pneumonia due to COVID-19 virus Yes
Moderna COVID-19 Vaccine EUA No immediate reactions.  Fatigue, chills, and mild headache experienced about an hour after the vaccination, for two hours (napped during that time).  No other reactions till the evening of day 8 -- itching, redness, and swelling  at vaccination site  (the size of a cookie), along with bruise marks along the bottom perimeter of the swelled muscle.  Itching decreased on day 9 and it barely itched on day 10, but  the muscle that was vaccinated remains swelled,  dark red, and hard,
This is a spontaneous report received from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 pm (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (BP) and oyster allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration in the left arm on 24Feb2021 at 11:00 am as a single dose for COVID-19 immunisation. Prior to vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified medications within 2 weeks of vaccination. On 18Mar2021, patient experienced soreness at injection site, headache and chills. No therapeutic measures were received for any event. The clinical outcome of the events soreness at injection site, headache and chills was resolved on 18Mar2021.   No follow-up attempts are needed. No further information is expected.
pt recvd vax & exp migraine headache; pt exp recurrence of migraine w/ 2nd dose of vax;
Immediately felt tightness in chest. Has continued on and off many times a day to this time. Continues now along with periods of difficulty breathing. Today upon waking tightness in chest felt intensified and continues now (evening). Midday experienced sudden vertigo and double vision lasting over a minute along with dizziness. I had already eaten lunch. Primary Dr ordered me to emergency room. Extensive testing along with chest x-ray and EKG performed. No abnormalities were found.  ED doctor said a State test of some sort would tell us if it is an actual allergic reaction or an intensive immune response. He said it would take a few days for results.  I was given diagnosis of vaccine reaction and sent home for rest. Advised to return if symptoms get worse. Tightness in chest continues at this time. Fatigue and headache have also returned.
drawing up Pfizer covid vaccine and the medication got into her eyes; has irritation in her eyes; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program (002191).  A 42 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OCCUPATIONAL EXPOSURE TO PRODUCT (non-serious), outcome "unknown", described as "drawing up Pfizer covid vaccine and the medication got into her eyes"; EYE IRRITATION (non-serious), outcome "unknown", described as "has irritation in her eyes". Therapeutic measures were taken as a result of occupational exposure to product. Additional information: Clinical course: The patient was drawing up Pfizer covid vaccine and the medication got into her eyes. She has rinsed it well but has irritation in her eyes. Caller wanted guidance on what they need to do.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Terrible soreness of muscle on side of neck (trapezius), base of head and back. Hurt when swallowing. Hurts when head is rotated to left, right and back.
flu shot is wicked...almost killed my son; Initial information received on 24-Dec-2021 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who had  flu shot is wicked...almost killed my son while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient developed a serious flu shot is wicked...almost killed my son (unevaluable event) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (flu shot is wicked...almost killed my son).  At time of reporting, the outcome was Unknown for the event flu shot is wicked...almost killed my son.
Pt presented to hospital with altered mental status with acute cva, and hypertensive encepalopathy. Related to lack of gaudianship and placement pt has an extended hopital stay and tested positive for covid asymptomatic, Pt was able to be discharged to a residential facility.
I developed what appeared to be a severe shingles outbreak, manifesting first on the left side of my trunk, then within 10-12 hours also manifesting on the right side. The rash then spread up into my chest and neck, upper back, and then down both arms.
After pnuemo inj. pt had pain in left buttock, temp 100.2 that evening. Pain radiated down leg to knee and pt had difficulty walking, was noted to drag left leg due to weakness in left leg.
No other adverse effects were reported in the patient; a patient received an expired dose of MMR II; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.  On 25-NOV-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status of rHA (recombinant human albumin)) (M-M-R II) (lot # N032750, expiration date 20-NOV-2019; strength, dose and route were not reported) for prophylaxis (expired vaccine used). No other adverse effects were reported in the patient.
On Friday July 16,Patient was wrongly administered 0.5ml of Pfizer Vaccine Intramuscular instead of 0.3ml by the Volunteer Vaccinator. Management was informed ,Incident report filed and patients are being notified by medical staff.
29 min after 2nd Moderna vaccine, pt started to feel shaky and said her "tongue felt swollen". Denies difficulty breathing. VS 150/84, HR 70, SpO2 97% RA.  5 minutes later this started to get better 25 min after onset pt said she was feeling better , "just anxious". She does have hx of anxiety.
Female client received the 2nd Pfizer vaccine (lot # 30145BA exp 10/30/2021) at 11:05AM, in her left arm. Client arrived in observation area at 11:09 to complete her 30-minute observation period. Client was offered water bottle and drank it during her 30-minute wait. At 11:40 AM, client reports to EMT stiff neck and headache that began two minutes ago. EMT advised client to stay in observation to be assessed. PHN arrives and offers client juice. At 11:42AM client states that additionally her jaw is ?numb and feels tight? and her left shoulder is ?tingling and radiating to the left side of her neck.?. Client denies dizziness, blurry vision, shortness of breath, and chest pain. Client?s skin is dry and appropriate for ethnicity, is alert and oriented, and is able to swallow. At 11:44AM vital signs were taken.  Client had a blood pressure of 150/90 on her left arm, oxygen saturation of 98%, and heart rate of 62bpm. Client states that she has a past medical history of anxiety and headache was up to an 8 out of 10. At 11:50 AM, client takes her routine inhaler. Client states that her headache is down to a 3 out of 10 and her shoulder is at 7 out of 10 on pain scale. At 11:53 AM vital signs are taken again, this time on the client?s right arm. Blood pressure is at 172/90, heart rate is regular at 60bpm, oxygen saturation is at 97%, and respirations are at 16. At 11:55AM client states her neck pain is at 5 out of 10, and that her jaw is ?feeling better? and that ?the feeling is dissipating.? Client past medical history includes allergy to sulfa and erythromycin, hypertension, asthma, and chronic obstructive pulmonary disease. During vaccination, client told vaccinator that after having sulfa and erythromycin by mouth, she had difficulty breathing and chest tightness but did not require epinephrine. The medical team was consulted at 12:00PM.  Per CDC and medical consult, no intervention is needed at this time. Client was educated on when to call 911 and was advised to follow up with her primary care provider in 24 hours. At 12:10 PM, client stood up and states she feels ?heavier,? and pain is continuing to decrease. Client states that pain is currently at 4 out of 10. Client declined transport to hospital via ambulance. At 12:25 PM, client reports pain is now at a 2 out of 10 and her shoulder is now ?like a deep ache but is not radiating anymore.? Client denies dizziness and has stable gait. Client leaves in stable condition.
This spontaneous report as received from a nurse via a company representative refers to a patient of unknown age with no pertinent medical history. On an unknown date the patient was vaccinated with VAQTA (0.5ml/1 shot, frequency, lot # and expiration date were unknown) intramuscular. On an unknown date the patient developed a local reaction after receiving VAQTA. The patient sought unspecified medical attention. No lab diagnostics studies were performed. The outcome of the event was unknown. Additional information has been requested.
A few weeks after vaccination, pt developed severe intolerance to beef products. Can not be around the smell at all. When eating the product, will vomit it up immediately. The only change was the vaccination a few weeks prior. No recent tick bite and no actual allergic reaction to the meat itself. Pt requested that it be reported in case it was related.
started to itch; Scratchy throat; Mental confusion; tightness in throat; Her throat tightening made her anxious and her respiratory status worse; Her throat tightening made her anxious and her respiratory status worse; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9262), via an unspecified route of administration, at the age of 74 years, administered on the left arm on 08Feb2021 12:45 at a SINGLE DOSE for covid-19 immunisation. Medical history included ongoing hypersensitivity. Additional Information for Other Conditions: medications, cloves, spices, MSG, processed foods and she can't take any antibiotics. There were no concomitant medications. The patient wanted to report a less severe reaction she experienced within 10 minutes of the first dose 08Feb2021. After her vaccine within 10 minutes, she started to itch. The patient had a scratchy throat, mental confusion, tightness in her throat. The tightness in her throat she usually experiences with clove, food allergies and antibiotics. She was familiar with what was happening. The side effects did go away. They asked her to stay 30 minutes. As soon as she left, she took one Benadryl and 10 min later she took a second one. Then, it subsided. Her itching did go into the next day. Her throat tightening made her anxious and her respiratory status worse. It happened so quick. Her first concern was conflicting facts sheets in regards to taking the second dose. The patient wanted to know what was recommended. Should she take the second dose. She has never had anaphylaxis so she doesn't have an Epipen. She can take Benadryl which has gotten her out of more severe responses before. Therapeutic measures (Benadryl) were taken as a result of the events. The outcome of the event itch was recovered on 09Feb2021 while other events were recovered on 08Feb2021.
general malaise; All experienced similar symptoms, primarily the next day, including injection site soreness; fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (general malaise), VACCINATION SITE PAIN (All experienced similar symptoms, primarily the next day, including injection site soreness) and FATIGUE (fatigue) in a 13-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    No Medical History information was reported.   On 04-Nov-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) (unknown route) 1 dosage form. On 05-Nov-2023, the patient experienced MALAISE (general malaise), VACCINATION SITE PAIN (All experienced similar symptoms, primarily the next day, including injection site soreness) and FATIGUE (fatigue). At the time of the report, MALAISE (general malaise), VACCINATION SITE PAIN (All experienced similar symptoms, primarily the next day, including injection site soreness) and FATIGUE (fatigue) had resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use information was not provided by reporter.  Patient was vaccinated with COVID booster 2023 on 04-Nov-2023 and received a Flu vaccine at the same time.    Primarily the next day experienced injection site soreness, fatigue and general malaise. All symptoms were resolved within the following 24-48 hours.  It was reported that administered at a pharmacy without a treating physician.  Treatment medication use information was not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-749068, US-MODERNATX, INC.-MOD-2023-749069, US-MODERNATX, INC.-MOD-2023-749071 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-749068:Same Reporter  US-MODERNATX, INC.-MOD-2023-749069:Same reporter  US-MODERNATX, INC.-MOD-2023-749071:Same reporter
Breathing feels slowed/ not enough, afraid to sleep in case I'm not breathing well enough, intense fatigue, intense sense of trembling like when your blood sugar is low, cold mouth, chills
Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Patient did not experience any pain or discomfort on injection.  After dose was administered pt felt a muscle cramp under right arm pit. After 15 min she returned to report she was experience tinging, numbness and weakness in right arm/hand.  If it persisted she was going to follow up with healthcare provider.
Aproximately 15 minutes after receiving the dose (and while being observed for 30 minutes for past allergic reaction history), the patient stated that her Parkinson's tremors had suddenly become more severe.  Prior to the injection, she would have small tremors in hands and legs on occasion but not as severe as she was experiencing afterwards.  Patient was examined and had normal vital signs, O2 saturations of 93% on room air (hx of Copd), and was negative for stroke evaluation.  We placed her on her own 02 which she generally has on when short of breath, and ECG showed a sinus rhythm with a bundle branch block.  We continued to monitor the patient which she stated her symptoms where "better" but continued to have sporadic Parkinson's like tremors which facility stated was more significant than normal.  It was decided that the patient would be warrant an emergency room evaluation.  The patient was transported to hospital.
Metallic taste in mouth, followed by numbness, tingling in palate, throat, tongue and lips, followed by swelling of the tongue and lips
Vaccines given 6-17-13. Fever that night and hives starting the next day. Increased hives and edema sent patient to ER - improvement on DECADRON. Hives increased and wheezing today 6-21-13 --> responding well to therapy.
Vaccine rxn, r leg, 2 x 1 1/4 cm red, warm area. Bactrim/Bactroban.
No adverse effects; the patient received the first dose of GARDASIL 9 on an unspecified date 8 months ago and the second dose on 28-SEP-2019; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concomitant medications, drug reactions or allergies were not reported.  On an unspecified date in January 2019 (reported as 8 months ago), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, lot #, expiration date, route of administration and anatomical location were not provided) and on 28-SEP-2019, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # N019104, expiration date: 02-MAR-2020) (dose, route of administration and anatomical location were not provided) (inappropriate schedule of product administration). No adverse effects were reported.
sore arm; left dizzy; coldness that started in her sternum, radiated to chest, lungs and down arms to wrists; Pressure in chest area; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), DIZZINESS (left dizzy), FEELING COLD (coldness that started in her sternum, radiated to chest, lungs and down arms to wrists), CHEST DISCOMFORT (Pressure in chest area) and FATIGUE (Tiredness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Vegetable allergy (Green peppers, Egg plant), Drug allergy (Parabens, Codeine), Toothpaste allergy, Seasonal allergy (Respiratory/seasonal allergies) and High cholesterol. Concomitant products included ROSUVASTATIN and EZETIMIBE for High cholesterol, UBIDECARENONE (COQ10 [UBIDECARENONE]) and LUTEIN [XANTOFYL] for Supplementation therapy, DIPHENHYDRAMINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL ALLERGY & SINUS), EZETIMIBE (ZETIA), MULTIVITAMIN [VITAMINS NOS] and CENTRUM SILVER +50 for an unknown indication.    On 10-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), DIZZINESS (left dizzy), FEELING COLD (coldness that started in her sternum, radiated to chest, lungs and down arms to wrists), CHEST DISCOMFORT (Pressure in chest area) and FATIGUE (Tiredness). On 10-Mar-2021, PAIN IN EXTREMITY (sore arm), DIZZINESS (left dizzy) and FEELING COLD (coldness that started in her sternum, radiated to chest, lungs and down arms to wrists) had resolved. At the time of the report, CHEST DISCOMFORT (Pressure in chest area) and FATIGUE (Tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (sore arm), DIZZINESS (left dizzy), FEELING COLD (coldness that started in her sternum, radiated to chest, lungs and down arms to wrists), CHEST DISCOMFORT (Pressure in chest area) and FATIGUE (Tiredness) to be related.    This case was linked to MOD-2021-130045 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Patient demographic details, Past Medical history, 2nd dose information, concomitant medications, reporter causality, and outcome of events added.
My right arm is weak; no strength; hurts badly to bend move laying on it.; The joints are what hurts the most; I can no longer grip anything.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Sep2021 11:00 (Lot number: 301308A) at the age of 49 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: MUSCULAR WEAKNESS (non-serious) with onset 21Sep2021 01:30, outcome "not recovered", described as "My right arm is weak"; ASTHENIA (non-serious) with onset 21Sep2021 01:30, outcome "not recovered", described as "no strength"; PAIN IN EXTREMITY (non-serious) with onset 21Sep2021 01:30, outcome "not recovered", described as "hurts badly to bend move laying on it."; ARTHRALGIA (non-serious) with onset 21Sep2021 01:30, outcome "not recovered", described as "The joints are what hurts the most"; GRIP STRENGTH DECREASED (non-serious) with onset 21Sep2021 01:30, outcome "not recovered", described as "I can no longer grip anything.". Therapeutic measures were not taken as a result of muscular weakness, asthenia, pain in extremity, arthralgia, grip strength decreased.  Additional information: Prior to vaccination, patient was diagnosed with COVID, Since the vaccination, patient has not been tested for COVID-19  Follow-up (12Oct2021): Follow-up attempts are completed. No further information is expected.
No additional AEs were reported.; Medical assistant reported that an expired MMR II vaccine was given to a patient today 8/10/2023.; This spontaneous report has been received from a health care professional, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 10-AUG-2023, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) subcutaneous injection, as prophylaxis (lot number: U022316, which was determined to be valid, with an expiration date on 15-JUL-2023, therapy type: rHA), with sterile diluent (MERCK STERILE DILUENT) diluent (lot number: W000452, which was determined to be valid, with an expiration date on 23-JUL-2024) (expired product administered) (strengths, doses, schemes, routes and anatomical locations of administration were not reported).  No additional event was reported.   No further information was reported.
Tremors shaking hot cold sweats elevated blood pressure fatigue confusion blurred vision couldn?t quench my thirst dry mouth unsteadiness
Information has been received on 10/2/02 from a licensed practical nurse concerning a female who "1.5 years ago" was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. Subsequently the pt developed a generalized rash and itching. The pt sought unspecified medical attention. Additional info has been requested.